Servier is an independent international pharmaceutical laboratory focused on developing therapeutic solutions for rare diseases, oncology (including colorectal cancer, gliomas, and cholangiocarcinomas), and neurological disorders. The firm emphasizes patient-centric innovation, digital health integration, and long-term research to address unmet medical needs, particularly in rare and aggressive conditions.
Bevorzugte Reifephase für die erste Finanzierung.
Rare diseases, oncology (cancer), neurological disorders, cardiovascular diseases, and digital health solutions
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
